Short answer
ABEONA THERAPEUTICS INC. (ABEO) filed an 8-K current report with the SEC on September 15, 2026 reporting Item 7.01 (Regulation FD Disclosure). Updated investor presentation for H.C. Wainwright’s 28th Annual Global Investment Conference on September 15, 2026.
ABEONA THERAPEUTICS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation for H.C. Wainwright’s 28th Annual Global Investment Conference on September 15, 2026
- Presentation likely provides current corporate, clinical and strategic updates relevant to investor expectations
- Exhibit 99.1 contains the substantive disclosures investors should review
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ABEONA THERAPEUTICS INC. 8-K filings
Get the next ABEO 8-K as it lands
Follow ABEO for push alerts, or ask the research agent what this filing means.